In the future, the findings from our study, especially the abundance of the 57 proteins as VHL substrate candidates, should be tested through immunohistochemistry in human ccRCC tumors stratified into VHL-defective and VHL-intact subgroups. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.